Details

Autor(en) / Beteiligte

• Brudner, Matthew
• Karpel, Marshall
• Lear, Calli
• Chen, Li
• Yantosca, L Michael
• Scully, Corinne
• Sarraju, Ashish
• Sokolovska, Anna
• Zariffard, M Reza
• Eisen, Damon P
• Mungall, Bruce A
• Kotton, Darrell N
• Omari, Amel
• Huang, I-Chueh
• Farzan, Michael
• Takahashi, Kazue
• Stuart, Lynda
• Stahl, Gregory L
• Ezekowitz, Alan B
• Spear, Gregory T
• Olinger, Gene G
• Schmidt, Emmett V
• Michelow, Ian C
• Schneider, Bradley S.

Titel

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors

Ist Teil von

• PloS one, 2013-04, Vol.8 (4), p.e60838-e60838

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Mannose-binding lectin (MBL) is a key soluble effector of the innate immune system that recognizes pathogen-specific surface glycans. Surprisingly, low-producing MBL genetic variants that may predispose children and immunocompromised individuals to infectious diseases are more common than would be expected in human populations. Since certain immune defense molecules, such as immunoglobulins, can be exploited by invasive pathogens, we hypothesized that MBL might also enhance infections in some circumstances. Consequently, the low and intermediate MBL levels commonly found in human populations might be the result of balancing selection. Using model infection systems with pseudotyped and authentic glycosylated viruses, we demonstrated that MBL indeed enhances infection of Ebola, Hendra, Nipah and West Nile viruses in low complement conditions. Mechanistic studies with Ebola virus (EBOV) glycoprotein pseudotyped lentiviruses confirmed that MBL binds to N-linked glycan epitopes on viral surfaces in a specific manner via the MBL carbohydrate recognition domain, which is necessary for enhanced infection. MBL mediates lipid-raft-dependent macropinocytosis of EBOV via a pathway that appears to require less actin or early endosomal processing compared with the filovirus canonical endocytic pathway. Using a validated RNA interference screen, we identified C1QBP (gC1qR) as a candidate surface receptor that mediates MBL-dependent enhancement of EBOV infection. We also identified dectin-2 (CLEC6A) as a potentially novel candidate attachment factor for EBOV. Our findings support the concept of an innate immune haplotype that represents critical interactions between MBL and complement component C4 genes and that may modify susceptibility or resistance to certain glycosylated pathogens. Therefore, higher levels of native or exogenous MBL could be deleterious in the setting of relative hypocomplementemia which can occur genetically or because of immunodepletion during active infections. Our findings confirm our hypothesis that the pressure of infectious diseases may have contributed in part to evolutionary selection of MBL mutant haplotypes.